Alzheimer's congress. Drug shows promise for advanced disease
Marx, J.
Science 289(5478): 375-377
2000
ISSN/ISBN: 0036-8075 PMID: 10939942 Document Number: 525129
Document emailed within 1 workday
Related Documents
Morris, M.C. 2004: Diet and Alzheimer's disease: what the evidence shows Medgenmed: Medscape General Medicine 6(1): 48Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Mauch, P. 1995: Does adjuvant radiation therapy hold promise for improved outcome in advanced Hodgkin's disease? Cancer Journal from Scientific American 1(4): 247-249
2012: Subcutaneous trastuzumab (Herceptin) injection shows promise Oncology 26(9): 873
2016: XI SOLANEP International Congress / XV Cystic Fibrosis Latinamerican Congress / XV Brazilian Congress of Pediatric Pulmonology Pediatric Pulmonology 51 Suppl. 42: S7
2016: XI SOLANEP International Congress / XV Cystic Fibrosis Latinamerican Congress / XV Brazilian Congress of Pediatric Pulmonology Pediatric Pulmonology 51 Suppl. 42: S7
McCrea, J.B.; Erwin, W.G.; Uretsky, S.D.; Veatch, R.M. 1990: Forgoing antimicrobial therapy for a patient with advanced Alzheimer's disease American Journal of Hospital Pharmacy 47(7): 1588; Discussion: 1588-1591
Münch, G.; Gasic-Milenkovic, J.; Arendt, T. 2003: Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer's disease Journal of Neural Transmission. Supplementum 2003(65): 63-71
Mulligan, R.; Juillerat, A.C. 1997: Non-drug alternatives in Alzheimer disease Praxis 86(35): 1355-1358
Derouesné, C.; Baudouin-Madec, V.; Kerromes, I. 1998: Non-drug management of Alzheimer's disease La Revue du Praticien 48(17): 1918-1922
Lacomblez, L. 1998: Drug therapy strategies in Alzheimer's disease La Revue du Praticien 48(17): 1913-1917
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Cutler, N.R.; Sramek, J.J. 1998: Exploratory studies: implications for drug development in Alzheimer's disease Revue Neurologique (Paris) 154(Suppl): S131-S136
Nordstedt, C.; Näslund, J.; Tjernberg, L.O.; Terenius, L. 1995: A breakthrough for research on Alzheimer disease. a model for drug testing Lakartidningen 92(18): 1899-1900
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Crismon, M.L. 1998: Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease PharmacoTherapy 18(2 Part 2): 47-54; Discussion: 79-82
Otomo, E. 1988: Drug therapy of Alzheimer's disease. General concepts on nootropic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1569-1574